股本结构
单位：万股
| 公告日期 | 2024-11-07 | 2024-11-07 | 2024-08-01 | 2024-08-01 | 2024-04-29 | 2024-04-30 |
|---|---|---|---|---|---|---|
| 证券总股本 | 5110.92 | 5111.00 | 5111.81 | 5101.46 | 5101.85 | 5101.82 |
| 普通股本 | 5110.92 | 5111.00 | 5111.81 | 5101.46 | 5101.85 | 5101.82 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-11-05 | 2024-09-30 | 2024-07-30 | 2024-06-30 | 2024-04-25 | 2024-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-11-07 | 5110.92 | 未披露 | 定期报告 | 2024-11-05 |
| 2024-11-07 | 5111.00 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Issuance of common stock for employee stock option exercises for cash
RSA forfeitures for terminations, net and stock-based compensation
|
2024-09-30 |
| 2024-08-01 | 5111.81 | 未披露 | 定期报告 | 2024-07-30 |
| 2024-08-01 | 5101.46 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Issuance of common stock for employee stock option exercises for cash
RSA forfeitures for terminations, net and stock-based compensation
|
2024-06-30 |
| 2024-04-29 | 5101.85 | 未披露 | 定期报告 | 2024-04-25 |
| 2024-04-30 | 5101.82 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Restricted Shares Award (RSA) issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of Restricted Stock Units (RSU) and stock-based compensation
|
2024-03-31 |
| 2024-02-29 | 5100.34 | 未披露 | 定期报告 | 2024-02-26 |
| 2024-02-22 | 5100.46 | 未披露 | 定期报告 | 2024-02-08 |
| 2024-02-22 | 5076.93 | 未披露 | 定期报告 | 2024-01-04 |
| 2024-02-29 | 5077.05 | 未披露 |
更多>>
From December 31,2022 to December 31,2023
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of RSU and stock-based compensation
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for acquisition of in-process research & development
|
2023-12-31 |
| 2023-10-31 | 5066.20 | 未披露 | 定期报告 | 2023-10-27 |
| 2023-10-31 | 5066.92 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of RSU and stock-based compensation
RSA issuances and forfeitures for terminations, net and stock-based compensation
|
2023-09-30 |
| 2023-07-31 | 5046.08 | 未披露 | 定期报告 | 2023-07-28 |
| 2023-07-31 | 5046.13 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Issuance of common stock for acquisition of in-process research & development
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for employee stock option exercises for cash
|
2023-06-30 |
| 2023-05-02 | 5038.37 | 未披露 | 定期报告 | 2023-04-27 |
| 2023-05-02 | 5011.07 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of Restricted Stock Units (RSU) and stock-based compensation
Restricted Shares Award (RSA) issuances and forfeitures for terminations, net and stock-based compensation
|
2023-03-31 |
| 2023-03-01 | 4996.36 | 未披露 | 定期报告 | 2023-02-27 |
| 2023-03-01 | 4954.67 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of RSU and stock-based compensation
RSA issuances and forfeitures for terminations, net and stock-based compensation
Follow-on offering - issuance of 2,012,500 shares at $63.85 per share, less offering costs of $192
|
2022-12-31 |
| 2022-11-09 | 4953.00 | 未披露 | 定期报告 | 2022-11-07 |
| 2022-11-09 | 4947.96 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for employee stock option exercises for cash
Follow-on offering - issuance of 2,012,500 shares at $63.85 per share, less closing costs of $192
|
2022-09-30 |
| 2022-08-05 | 4912.36 | 未披露 |
更多>>
1.Common stock offered by 1,750,000 shares of common stock
2.Under the terms of the Underwriting Agreement, the Company also granted to the Underwriter an option, exercisable in whole or in part at any time for a period of 30 days from the date of the Underwriting Agreement, to purchase up to an additional 262,500 shares of Common Stock from the Company at a price of $63.85 per share of Common Stock, which option was exercised in full prior to the closing of the Offering. The Offering closed on August 5, 2022.
|
2022-08-05 |
| 2022-08-01 | 4711.11 | 未披露 | 定期报告 | 2022-07-28 |
| 2022-08-01 | 4711.77 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
|
2022-06-30 |
| 2022-05-05 | 4707.01 | 未披露 | 定期报告 | 2022-05-03 |
| 2022-04-15 | 4699.91 | 未披露 | 定期报告 | 2022-04-01 |
| 2022-05-05 | 4700.29 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (RSA) issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for vesting of Restricted Stock Units (RSU) and stock-based compensation
|
2022-03-31 |
| 2022-03-01 | 4695.70 | 未披露 | 定期报告 | 2022-02-25 |
| 2022-03-01 | 4633.02 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for vesting of RSU and stock-based compensation
Follow-on offering - issuance of 4,025,000 shares at $50.00 per share, less offering costs of $11,272
Issuance of common stock for acquisition of Contura Limited
Issuance of common stock for exclusive license asset
|
2021-12-31 |
| 2021-11-04 | 4629.73 | 未披露 | 定期报告 | 2021-11-02 |
| 2021-11-04 | 4625.88 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
|
2021-09-30 |
| 2021-08-05 | 4613.45 | 未披露 | 定期报告 | 2021-08-03 |
| 2021-08-05 | 4609.10 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
Follow-on offering-issuance of 4,025,000 shares at $50.00 per share, less closing costs of $11,272
|
2021-06-30 |
| 2021-05-14 | 4532.71 | 未披露 |
更多>>
1.Common stock offered by the company 3,500,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 41,827,068 shares of common stock outstanding as of March 31, 2021.
|
2021-05-14 |
| 2021-05-07 | 4190.40 | 未披露 | 定期报告 | 2021-05-03 |
| 2021-04-30 | 4190.25 | 未披露 | 定期报告 | 2021-04-27 |
| 2021-05-07 | 4182.71 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (RSA) issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for vesting of Restricted Stock Units (RSU) and stock based compensation
Issuance of common stock for acquisition of Contura Holdings Limited
Issuance of common stock for exclusive license asset
|
2021-03-31 |
| 2021-03-01 | 4152.34 | 未披露 | 定期报告 | 2021-02-25 |
| 2021-03-01 | 3993.10 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for vesting of RSU and stock-based compensation
Follow-on offering - issuance of 4,600,000 shares at $32.50 per share, less closing costs of $9,013
|
2020-12-31 |
| 2020-11-04 | 3980.94 | 未披露 | 定期报告 | 2020-11-02 |
| 2020-11-04 | 3975.36 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
|
2020-09-30 |
| 2020-08-06 | 3952.30 | 未披露 | 定期报告 | 2020-08-03 |
| 2020-08-06 | 3946.24 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net
Follow-on offering - issuance of 4,600,000 shares at $32.50 per share, less closing costs of $9,013
|
2020-06-30 |
| 2020-05-12 | 3911.07 | 未披露 |
更多>>
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) (“Axonics”), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced the closing of its public offering of 4,600,000 shares of common stock at the public offering price of $32.50 per share, which includes the shares purchased pursuant to the exercise in full of the underwriters’ option to purchase up to an additional 600,000 shares of its common stock.
|
2020-05-12 |
| 2020-05-05 | 3451.90 | 未披露 | 定期报告 | 2020-05-01 |
| 2020-04-29 | 3451.31 | 未披露 | 定期报告 | 2020-04-28 |
| 2020-05-05 | 3451.07 | 未披露 |
更多>>
From December 31, 2019 to March 31, 2020
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (“RSA”) issuances and forfeitures for terminations, net
Restricted Stock Units (“RSU”) issuances and forfeitures for terminations, net
|
2020-03-31 |
| 2020-03-04 | 3429.22 | 未披露 | 定期报告 | 2020-03-02 |
| 2020-03-04 | 3411.10 | 未披露 |
更多>>
from December 31, 2018 to December 31, 2019
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (“RSA”) and stock option issuances and forfeitures for terminations, net
Follow-on offering - issuance of 5,345,000 shares at $22.00 per share, less closing costs of $7,141
Issuance of common stock for warrant exercise
|
2019-12-31 |
| 2019-11-22 | 3322.89 | 未披露 | 定期报告 | 2019-11-22 |
| 2019-11-06 | 2860.28 | 未披露 | 定期报告 | 2019-11-05 |
| 2019-11-14 | 2863.39 | 未披露 |
更多>>
From June 30, 2019 to September 30, 2019
Issuance of common stock for employee stock option exercises for cash
RSA and stock option issuances and forfeitures for terminations, net
Issuance of common stock for warrant exercise
|
2019-09-30 |
| 2019-08-05 | 2852.48 | 未披露 | 定期报告 | 2019-08-01 |
| 2019-08-05 | 2848.07 | 未披露 |
更多>>
from March 31, 2019 to June 30,2019
Issuance of common stock for employee stock option exercises for cash
RSA and stock option issuances and forfeitures for terminations, net
Issuance of common stock for warrant exercise
|
2019-06-30 |
| 2019-07-09 | 2846.81 | 未披露 | 定期报告 | 2019-06-28 |
| 2019-05-08 | 2826.58 | 未披露 | 定期报告 | 2019-05-03 |
| 2019-04-30 | 2822.46 | 未披露 | 定期报告 | 2019-04-29 |
| 2019-05-08 | 2820.11 | 未披露 |
更多>>
from December 31, 2018 to March 31, 2019
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (“RSA”) and stock option issuances and forfeitures for terminations, net
|
2019-03-31 |
| 2019-03-05 | 2784.09 | 未披露 | 定期报告 | 2019-03-01 |
| 2019-03-05 | 2780.69 | 未披露 |
更多>>
from December 31, 2017 to December 31, 2018
Conversion of preferred stock to common stock
Issuance of Series C Preferred Stock at $9.00 per share for cash, net of issuance costs of $199
Issuance of common stock for employee stock option exercises for promissory notes
Issuance of common stock for employee stock option exercises for cash
Repurchase of common stock
Initial public offering - issuance of 9,200,000 shares at $15.00 per share, less closing costs of $11,951
|
2018-12-31 |
| 2018-12-11 | 2780.51 | 未披露 | 定期报告 | 2018-12-11 |
| 2018-11-01 | 2663.86 | 未披露 |
更多>>
1.Common stock offered 8,000,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 18,638,600 shares of common stock outstanding as of June 30, 2018, after giving effect to the conversion of all of our outstanding shares of preferred stock
|
2018-10-31 |
| 2018-10-22 | 1863.86 | 未披露 | 定期报告 | 2018-06-30 |
From June 30, 2024 to September 30, 2024
Issuance of common stock for employee stock option exercises for cash
RSA forfeitures for terminations, net and stock-based compensation
From March 31, 2024 to June 30, 2024
Issuance of common stock for employee stock option exercises for cash
RSA forfeitures for terminations, net and stock-based compensation
From December 31, 2023 to March 31, 2024
Restricted Shares Award (RSA) issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of Restricted Stock Units (RSU) and stock-based compensation
From December 31,2022 to December 31,2023
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of RSU and stock-based compensation
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for acquisition of in-process research & development
From June 30, 2023 to September 30, 2023
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of RSU and stock-based compensation
RSA issuances and forfeitures for terminations, net and stock-based compensation
From March 31, 2023 to June 30, 2023
Issuance of common stock for acquisition of in-process research & development
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for employee stock option exercises for cash
From December 31, 2022 to March 31, 2023
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of Restricted Stock Units (RSU) and stock-based compensation
Restricted Shares Award (RSA) issuances and forfeitures for terminations, net and stock-based compensation
From December 31, 2021 to December 31, 2022
Issuance of common stock for employee stock option exercises for cash
Issuance of common stock for vesting of RSU and stock-based compensation
RSA issuances and forfeitures for terminations, net and stock-based compensation
Follow-on offering - issuance of 2,012,500 shares at $63.85 per share, less offering costs of $192
From June 30, 2022 to September 30, 2022
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for employee stock option exercises for cash
Follow-on offering - issuance of 2,012,500 shares at $63.85 per share, less closing costs of $192
1.Common stock offered by 1,750,000 shares of common stock
2.Under the terms of the Underwriting Agreement, the Company also granted to the Underwriter an option, exercisable in whole or in part at any time for a period of 30 days from the date of the Underwriting Agreement, to purchase up to an additional 262,500 shares of Common Stock from the Company at a price of $63.85 per share of Common Stock, which option was exercised in full prior to the closing of the Offering. The Offering closed on August 5, 2022.
From March 31, 2022 to June 30, 2022
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
From December 31, 2021 to March 31, 2022
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (RSA) issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for vesting of Restricted Stock Units (RSU) and stock-based compensation
From December 31, 2020 to December 31, 2021
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for vesting of RSU and stock-based compensation
Follow-on offering - issuance of 4,025,000 shares at $50.00 per share, less offering costs of $11,272
Issuance of common stock for acquisition of Contura Limited
Issuance of common stock for exclusive license asset
From June 30, 2021 to September 30, 2021
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
From March 31, 2021 to June 30, 2021
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
Follow-on offering-issuance of 4,025,000 shares at $50.00 per share, less closing costs of $11,272
1.Common stock offered by the company 3,500,000 shares.
2.The number of shares of common stock to be outstanding after this offering is based on 41,827,068 shares of common stock outstanding as of March 31, 2021.
From December 31, 2020 to March 31, 2021
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (RSA) issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for vesting of Restricted Stock Units (RSU) and stock based compensation
Issuance of common stock for acquisition of Contura Holdings Limited
Issuance of common stock for exclusive license asset
from December 31, 2019 to December 31, 2020
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
Issuance of common stock for vesting of RSU and stock-based compensation
Follow-on offering - issuance of 4,600,000 shares at $32.50 per share, less closing costs of $9,013
From June 30, 2020 to September 30, 2020
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net and stock-based compensation
From March 31, 2020 to June 30, 2020
Issuance of common stock for employee stock option exercises for cash
RSA issuances and forfeitures for terminations, net
Follow-on offering - issuance of 4,600,000 shares at $32.50 per share, less closing costs of $9,013
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) (“Axonics”), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced the closing of its public offering of 4,600,000 shares of common stock at the public offering price of $32.50 per share, which includes the shares purchased pursuant to the exercise in full of the underwriters’ option to purchase up to an additional 600,000 shares of its common stock.
From December 31, 2019 to March 31, 2020
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (“RSA”) issuances and forfeitures for terminations, net
Restricted Stock Units (“RSU”) issuances and forfeitures for terminations, net
from December 31, 2018 to December 31, 2019
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (“RSA”) and stock option issuances and forfeitures for terminations, net
Follow-on offering - issuance of 5,345,000 shares at $22.00 per share, less closing costs of $7,141
Issuance of common stock for warrant exercise
From June 30, 2019 to September 30, 2019
Issuance of common stock for employee stock option exercises for cash
RSA and stock option issuances and forfeitures for terminations, net
Issuance of common stock for warrant exercise
from March 31, 2019 to June 30,2019
Issuance of common stock for employee stock option exercises for cash
RSA and stock option issuances and forfeitures for terminations, net
Issuance of common stock for warrant exercise
from December 31, 2018 to March 31, 2019
Issuance of common stock for employee stock option exercises for cash
Restricted Shares Award (“RSA”) and stock option issuances and forfeitures for terminations, net
from December 31, 2017 to December 31, 2018
Conversion of preferred stock to common stock
Issuance of Series C Preferred Stock at $9.00 per share for cash, net of issuance costs of $199
Issuance of common stock for employee stock option exercises for promissory notes
Issuance of common stock for employee stock option exercises for cash
Repurchase of common stock
Initial public offering - issuance of 9,200,000 shares at $15.00 per share, less closing costs of $11,951
1.Common stock offered 8,000,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 18,638,600 shares of common stock outstanding as of June 30, 2018, after giving effect to the conversion of all of our outstanding shares of preferred stock